Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21
Phase 31

Trial Status

Completed3

Role Distribution

Principal Investigator2
Other Roles1
PI Rate67%

Activity Timeline

Clinical Trials (3)

NCT00286845Completed
Use of the MiCK Assay for Apoptosis in AML
Leukemia, Myelocytic, Acute
Principalinvestigator
NCT00443196Phase 2/3Completed
Testing Drug Sensitivity of Ovarian, Fallopian and Primary Peritoneal Adenocarcinomas
AdenocarcinomaFallopian Tube NeoplasmsOvarian Neoplasms+1 more
Principalinvestigator

Research Network

Collaboration Network

13 collaborators·48 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Karl Rogers, MD

Nashville Oncology Associates

Related
2 trials

Shared therapeutic areas:

CancerOvarian Neoplasms

Worked with same sponsors:

Pierian Biosciences
Collaborated on 1 trial
Similarity Score24%

Peter F Jelsma, MD

St. Thomas Research Institute, LLC

Related
1 trials

Shared therapeutic areas:

Cancer

Worked with same sponsors:

Pierian Biosciences
Collaborated on 1 trial
Similarity Score14%

Swapnil P. Rajurkar, MD

Wilshire Oncology Medical Group, Inc.

Related
1 trials

Shared therapeutic areas:

Cancer

Worked with same sponsors:

Pierian Biosciences
Collaborated on 1 trial
Similarity Score14%

Jorge E Marcet, MD

Tampa Gerneral Hospital

Related
1 trials

Shared therapeutic areas:

Cancer

Worked with same sponsors:

Pierian Biosciences
Collaborated on 1 trial
Similarity Score14%

Richard D Michaelson, MD

Middle Tennessee Medical Center

Related
1 trials

Shared therapeutic areas:

Cancer

Worked with same sponsors:

Pierian Biosciences
Collaborated on 1 trial
Similarity Score14%

Raymond F Bluth, MD

Baptist Hospital Nashville

Related
1 trials

Shared therapeutic areas:

Cancer

Worked with same sponsors:

Pierian Biosciences
Collaborated on 1 trial
Similarity Score14%

Dirk Davidson, MD

Cumberland Medical Center

Related
1 trials

Shared therapeutic areas:

Cancer

Worked with same sponsors:

Pierian Biosciences
Collaborated on 1 trial
Similarity Score14%

Laura Lawson, MD

Tennessee Breast Specialists

Related
1 trials

Shared therapeutic areas:

Cancer

Worked with same sponsors:

Pierian Biosciences
Collaborated on 1 trial
Similarity Score14%

L. James Wudel Jr., MD

Tennessee Thoracic Surgical Specialists

Related
1 trials

Shared therapeutic areas:

Cancer

Worked with same sponsors:

Pierian Biosciences
Collaborated on 1 trial
Similarity Score14%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Related
19 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteCancer
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT00286845PrincipalInvestigator

Use of the MiCK Assay for Apoptosis in AML

Leukemia, Myelocytic, Acute
Completed
NCT00443196Phase 2/3PrincipalInvestigator

Testing Drug Sensitivity of Ovarian, Fallopian and Primary Peritoneal Adenocarcinomas

AdenocarcinomaFallopian Tube NeoplasmsOvarian Neoplasms+1 more
Completed
NCT00901264StudyDirector

Microculture Kinetic (MiCK) Apoptosis Test Results With Drug Treatment Results in Cancer Patients

Cancer
Completed

All 3 trials loaded